Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Trend Analysis of Gastric Cancer Incidence in Iran and Its Six Geographical Areas During 2000-2005

  • Haidari, Mohmmad (Kermanshah University of Medical Sciences) ;
  • Nikbakht, Mohammad Reza (Department of Pharmacology, Kermanshah University of Medical Sciences) ;
  • Pasdar, Yahya (Department of Nutrition, Kermanshah University of Medical Sciences) ;
  • Najafi, Farid (Department of Nutrition, Kermanshah University of Medical Sciences)
  • Published : 2012.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: gastric cancer is the fourth most common cancer worldwide. While it is one of the most common cancers in Iran, there are only limited data regarding incidence trends in the country. This study is the first of its type to investigate trends across six geographical areas during 2000-2005 using cancer registry data. Materials and methods: The registered data for gastric cancer cases in National Cancer Registry System were extracted from the Ministry of Health and Medical Education, Center for Disease Control & Management, code C16. First, according to WHO population, the sex-standardized incidence rate in both sexes and then the trends of incidence rate during 2000-2005 were investigated separately for different geographical areas of the country. Results: the incidence rates of gastric cancer in Iran and its six geographical areas during 2000-2005 were increasing albeit with differences in their slopes. The overall incidence rate increased from 2.8 in 2000 to 9.1 per 100,000 persons per year in 2005, rising from 4.1 to 13.2 in men. The average six-year incidence of gastric cancer in the central and northwestern border of Caspian Sea was 7.8 per 100,000 persons per year, while it was 0.9 per 100,000 persons per year in the border of the Persian Gulf. Generally the incidence rate in men was higher than in women. Conclusion: Iran is one of the high-risk areas for gastric cancer. Increase in incidence might continue in the future partly because of improvement in cancer registry systems as well as increase in risk of this cancer.

Keywords

References

  1. Al-Marhoon M S, Nunn S, Soames R W (2004). The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model. Dig Dis Sci, 49, 1116-22. https://doi.org/10.1023/B:DDAS.0000037797.62164.4e
  2. American Cancer Society (2009). Cancer Facts & Figures. ACS, ?, 2-6.
  3. Atherton J C (2006). The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Patho, 1, 63-96. https://doi.org/10.1146/annurev.pathol.1.110304.100125
  4. Babaei M, Mousavi S, Malek M (2005). Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pacific J Cancer Prev, 6, 159-64.
  5. Bafandeh Y, Farhang S, (2009). Subsite distribution of gastric cancer in an area of high prevalence-northwest Iran. J Epidemiol, 19, 202-5. https://doi.org/10.2188/jea.JE20080044
  6. Botterweck A, Schouten L J, Volovics A (2000). Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol, 29, 645-54. https://doi.org/10.1093/ije/29.4.645
  7. Boyle P, Dore J, Autier P (2004). Cancer of the skin: a forgotten problem in Europe. Ann Oncol, 15, 5-6. https://doi.org/10.1093/annonc/mdh032
  8. Brunetti D, Tamaro P, Tiribelli M (2009). Time trend in cancer incidence among 0-24 year-old residents of the Province of Trieste, Italy, 1972-2003. Epidemiol Prev, 33, 161-8.
  9. Center for Disease Control and Prevention NDCO (2007). Iranian Annual National Cancer Registration Report 2005 - 2006[in Persian]. Ministry of Health and Medical Education Press, Tehran pp 10-13.
  10. Chandanos E, Lagergren J (2008). Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer, 44, 2397-403. https://doi.org/10.1016/j.ejca.2008.07.031
  11. Fritz A, Percy C, Jack A, et al (2000). International Classification of Disease for Oncology, WHO, Geneva.
  12. Alikhani S, Delavari A, Alaedini F, et al (2009). A province-based surveillance system for the risk factors of noncommunicable diseases: a prototype for integration of risk factor surveillance into primary healthcare systems of developing countries. Public Health, 123, 358-64. https://doi.org/10.1016/j.puhe.2009.02.011
  13. A National Profile of Non communicable Disease Risk Factors in the I.R.Iran (2005). Persian, 1, 33-55.
  14. Derakhshan M H, Malekzadeh R, Watabe H, et al (2007). Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut, 10, 298-305.
  15. Eskandar H, Hossein S, Rahim M, et al (2006). Clinical profile of gastric cancer in Khuzestan, southwest of Iran. World J Gastroenterol, 12, 4832-5.
  16. Cabanes A, Vidal E, Aragones N, et al (2010). Cancer mortality trends in Spain: 1980-2007. Ann Oncol, 3, 14-20.
  17. Etemadi A, Sajdadi A, Semnani S, et al (2008). Cancer registry in Iran: a brief overview. Arch Iran Med, 11, 577-80.
  18. Fabrizio S, Antonio C (2007). Cancer mortality trends in the Umbria region of Italy 1978-2004: a joinpoint regression analysis. BioMed Central Ltd, 7, 1-9. https://doi.org/10.1186/1471-244X-7-1
  19. Forman D, Coleman M (1993). An internationalassociation between Helicobacter pylori infection and gastric cancer. Lancet, 341, 1359-62. https://doi.org/10.1016/0140-6736(93)90938-D
  20. Fuchs CS, Mayer RJ (1995). Gastric carcinoma. New Engl J Med, 6, 32-41.
  21. Ghadimi R, Taheri H, Suzuki S, et al (2007). Host and environmental factors for gastric cancer in Babol, the Caspian Sea Coast, Iran. Eur J Cancer Prev, 16, 192-5. https://doi.org/10.1097/01.cej.0000220639.61717.67
  22. Haruma K (2000). Trend toward a reduced prevalence of Helicobacter pylori infection, chronic gastritis, and gastric cancer in Japan. Gastroenterol Clin North Am, 29, 623-31. https://doi.org/10.1016/S0889-8553(05)70134-5
  23. He Y T, Hou J, Chen Z, et al (2008). Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China. Eur J Cancer Prev, 17, 71-6. https://doi.org/10.1097/CEJ.0b013e3282b6fd97
  24. Hossein N (2010). Helicobacter pylori and gastric cancer in the Middle East: a new enigma. World J Gastroenterol, 14, 3224-36.
  25. Igissinov S, Igissinov N, Moore MA, et al (2011). Trends of prevalent cancer incidences in the Aral-Syr darya ecological area of Kazakhstan. Asian Pacific J Cancer Prev, 12, 2299-303.
  26. Jung K, Won Y (2005). Cancer statistics in Korea: incidence, mortality and survival in 2005. JKMS, 24, 995-03.
  27. Kaneko S, Yoshimi I (2003). Mortality trend of stomach cancer in Japan: 1960-2000. Jpn J Clin. Oncol, 33, 105-6.
  28. Kaneko S, Yoshimura T (2001). Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989. Br J Cancer, 84, 400-5. https://doi.org/10.1054/bjoc.2000.1602
  29. Katz L, Steinitz R (1979). Cancer patterns in Israel: selected aspects. Isr J Med Sci, 15, 983-9.
  30. Kim M K, Sasaki S, Sasazuki S, et al (2004). Prospective study of three major dietary patterns and risk of gastric cancer in Japan. Int J Cancer, 110, 435-42. https://doi.org/10.1002/ijc.20132
  31. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
  32. Lambert R, Guilloux A, Oshima A, et al (2002). Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer, 97, 811-8. https://doi.org/10.1002/ijc.10150
  33. Malekzadeh R, Derakhshan M, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83.
  34. Malekzadeh R, Sotoudeh M, Derakhshan M, et al (2004). Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol, 57, 37-42. https://doi.org/10.1136/jcp.57.1.37
  35. Marmot M, Atinmo T, Byers T (2007). Food, nutrition, physical activity, and the prevention of cancer: a global perspectiver. AICR, Washington.
  36. Matsuzaka M, Fukuda S, Takahashi I, et al (2007). The decreasing burden of gastric cancer in Japan. Tohoku J Exp Med, 3, 207-19.
  37. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran metropolis: the first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med, 12,15-23.
  38. Moghimi-Dehkordi B, Safaee A, Vahedi M, et al (2011). Familial prevalence of cancer in Iran: a general population estimate. Asian Pacific J Cancer Prev, 12, 289-95.
  39. Moore M A, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pacific J Cancer Prev, 11, 17-32.
  40. Mousavi S M, Gouya M M, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  41. Najafi F, Mozaffari HR, Karami M, et al (2011). Trends in incidence of gastrointestinal tract cancers in Western Iran, 1993-2007. Iran Red Crescent Med J, 13, 805-10.
  42. Nooyi SC, Al-Lawati JA (2011). Cancer incidence in Oman, 1998-2006. Asian Pacific J Cancer Prev, 12, 1735-9.
  43. Parkin D M, Pisani P, Ferlay J (1980). Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 15, 827-41.
  44. Parkin DM, Bray F, Ferlay J (1999). Global cancer statistics. CA Cancer J Clin, 55, 33-64.
  45. Pinheiro P, Teyczinski J (2003). Cancer incidence and mortality in Portugal. EJC, 39, 2507-20. https://doi.org/10.1016/S0959-8049(03)00570-7
  46. Pirzadeh A, Doustmohammadian N, Khoshbaten M, et al (2011). Is there any association between Helicobacter pylori infection and laryngeal carcinoma? Asian Pacific J Cancer Prev, 12, 897-900.
  47. Pisani P, Parkin DM, Bray F, Ferlay J (1999). Erratum: estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 12, 870-73.
  48. Pisani P, Parkin DM, Munoz N, Ferlay J (1997). Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol, 10, 387-98.
  49. Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R (2009). The role of diet and other environmental factors in the causation of gastric cancer in Iran--a population based study. Int J Cancer, 125, 1953-60. https://doi.org/10.1002/ijc.24499
  50. Rafsanjani FN, Maghouli F, Vahedian J, Esmaeili F (2004). The effects of chronic consumption of heroin on basal and vagal electrical-stimulated gastric acid and pepsin secretion in rat. Saudi Med J, 25, 1356-59.
  51. Roshanaei G, Ghannad MS, Jafarabadi MA, et al (2011). Prognostic impact of risk factors in patients with gastric cancer in Iran. Asian Pacific J Cancer Prev, 12, 3005-7.
  52. Sadjadi A, Hislop T G, Gregory T, et al (2009). Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada. BMC Cancer, 9, 381-9. https://doi.org/10.1186/1471-2407-9-381
  53. Sadjadi A, Nouraie M, Mohagheghi MA, et al (2006). Cancer occurrence in Iran in 2002, an international perspective. Asian Pacific J Cancer Prev, 6, 359-63.
  54. Sasazuki S, Sasaki S, Tsugane S (2002). Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer, 101, 560-6. https://doi.org/10.1002/ijc.10649
  55. Sjodahl K, Lu Y, Nilsen TI, et al (2007). Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer, 1, 128-32.
  56. Terry P, Lagergren J, Hansen H, Wolk A, Nyren O (2001). Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev, 4, 365-9.
  57. Tomatis L, Aitio (1990). Cancer: causes, occurrence and control. IARC, Lyon, France.
  58. Tsugane S (2005). Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci, 96, 1-6. https://doi.org/10.1111/j.1349-7006.2005.00006.x
  59. Yavari P, Sadrolhefazi B, Mohagheghi MA, et al (2008). An epidemiological analysis of cancer data in an Iranian hospital during the last three decades. Asian Pacific J Cancer Prev, 9, 145-50.
  60. Yazdizadeh B, Jarrahi AM, Mortazavi H, et al (2006). Time trends in the occurrence of major GI cancers in Iran. Asian Pacific J Cancer Prev, 6, 130-4.

Cited by

  1. Survival Analysis of Patients with Gastric Cancer Undergoing Surgery at the Iran Cancer Institute: A Method Based on Multi-State Models vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6369
  2. Gastrointestinal, Liver and Biliary Tract Pathology: A Histopathological and Epidemiological Perspective from Pakistan with a Review of the Literature vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6997
  3. Estimation of the Gastric Cancer Incidence in Tehran by Two-Source Capture-recapture vol.14, pp.2, 2013, https://doi.org/10.7314/APJCP.2013.14.2.673
  4. Incidence Trends of Colorectal Cancer in the West of Iran During 2000-2005 vol.14, pp.3, 2013, https://doi.org/10.7314/APJCP.2013.14.3.1807
  5. Overview of Cancer Registration Research in the Asian Pacific from 2008-2013 vol.14, pp.8, 2013, https://doi.org/10.7314/APJCP.2013.14.8.4461
  6. Epidemiology Characteristics and Trends of Incidence and Morphology of Stomach Cancer in Iran vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2757
  7. Accuracy of Endoscopic Ultrasonography for Determination of Tumor Invasion Depth in Gastric Cancer vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3141
  8. Promyelocytic Leukemia (PML) Gene Mutations may not Contribute to Gastric Adenocarcinoma Development vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3523
  9. ) gene in patients with gastric cancer in an Iranian population vol.30, pp.3, 2015, https://doi.org/10.1111/jgh.12808
  10. Bayesian spatio-temporal analysis of stomach cancer incidence in Iran, 2003–2010 vol.32, pp.10, 2018, https://doi.org/10.1007/s00477-018-1531-3